Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
JPMA. the Journal of the Pakistan Medical Association|September 28, 2021
Dapagliflozin: The outcome of use as add-on therapy in real-life clinical setting -An AuditUmar Yousaf Raja, Ponnusamy Saravanan
JPMA. the Journal of the Pakistan Medical Association|September 28, 2021
Essential diagnostics and devices in primary care diabetesMuhammad Umar Wahab, Umar Yousaf Raja, Sanjay Kalra
JPMA. the Journal of the Pakistan Medical Association|June 9, 2026
The efficacyand safety of once weekly injectable semaglutide (Ozempic) among patients with Type 2 diabete sintertiary care hospital: A Retrospective StudyMisbah Jabeen, Umar Yousaf Raja, Osama Istiaq, et al.
Indian Journal of Endocrinology and Metabolism|March 18, 2022
Efficacy and Safety of Dulaglutide in Type 2 Diabetes Patients in Endocrinology Clinics of Islamabad, PakistanMatiullah Kamin, Sajjad Ali Khan, Umar Yousaf Raja, et al.
Diabetes, Obesity & Metabolism|June 28, 2026
Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From PakistanArshad Hussain, Muhammad Umar Wahab, Saleem Qureshi, et al.
BMC Endocrine Disorders|October 12, 2022
Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational studyIbrar Ahmed, Umar Yousaf Raja, Muhammad Umar Wahab, et al.
BMC Endocrine Disorders|November 29, 2022
Safety and efficacy of Empagliflozin in Pakistani Muslim patients with type 2 diabetes (SAFE-PAK); a randomized clinical trialAzizul Hasan Aamir, Umar Yousaf Raja, Faisal Masood Qureshi, et al.
BMC Nephrology|November 22, 2025
Comparative efficacy and safety of finerenone in diabetic kidney disease: a meta-analysis of Asian and non-Asian populationsSyed Abbas Raza, Aziz-Ur Rehman, Azizul Hasan Aamir, et al.
Pageof 1